Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» ArQule enrolls first patient in Phase 3 trial for carcinoma candidate tivantinib
ArQule enrolls first patient in Phase 3 trial for carcinoma candidate tivantinib
ArQule enrolls first patient in Phase 3 trial for carcinoma candidate tivantinib
Submitted by
admin
on January 31, 2013 - 10:48am
Source:
Yahoo/Fly on the Wall
News Tags:
Arqule
tivantinib
hepatocellular carcinoma
Headline:
ArQule enrolls first patient in Phase 3 trial for carcinoma candidate tivantinib
Do Not Allow Advertisers to Use My Personal information
